Menu

CanSense-CRC early detection novel blood test for bowel cancer (Raman spectroscopy and machine learning)

CanSense Ltd is an innovative medtech company bringing solutions to the NHS that solve the significant cancer detection problems faced today. Their reagent-free approach to cancer detection provides a sustainable and prudent healthcare solution that overcomes equality, diversity and inclusivity barriers.

‘The HRC bring a wealth of multi-disciplinary expertise and experience in bringing novel diagnostics into the NHS, and see the true value of disruptive technologies such as ours. Their wide network of NHS partners make them an ideal choice to work with for companies bringing new technologies to the NHS’. 

Website link: www.cansenseltd.com 

Follow us on LinkedIn / X
Lady using a mobile phone

Get in touch

Find out how to get involved in our research